Public-registry site landscape for NCT04676737, a Fuchs' Endothelial Dystrophy study sponsored by Trefoil Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04676737 (registry record) |
| Sponsor | Trefoil Therapeutics, Inc. |
| Condition(s) | Fuchs' Endothelial Dystrophy; Fuchs Dystrophy; Fuchs |
| Phase | PHASE2 |
| Listed sites | 11 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04676737 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →